Literature DB >> 950368

Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.

P Gorden, M A Lesniak, R Eastman, C M Hendricks, J Roth.   

Abstract

Plasma growth hormone (GH) from both normal and acromegalic patients comprises multiple immunoreactive components that can be separated by G-100 Sephadex gel filtration and measured by radioimmunoassay (RIA) and radioreceptor assay (RRA). The higher molecular weight immunoreactive components, from both normal and acromegalic subjects, have a lower RRA/RIA than does the lower molecular weight "little" GH component. The "little" GH component comprises a higher proportion of the total immunoreactive GH in acromegalic plasma than in normal plasma whether the data are expressed only in terms of the "big" and "little" components (89 vs. 71%), or as a function of total immunoreactive GH (76 vs. 55%), or whether the plasma is obtained in the basal or stimulated state for the acromegalic patients. When the RRA/RIA x 100 is determined for the isolated "little" component, the acromegalic has a significantly greater ratio than the normal (110 vs. 75%). We conclude that acromegalic plasma contains a higher proportion of the more radioreceptor active "little" GH component than does the normal and, in addition, that the "little" component from the acromegalic is more radioreceptor-active than the normal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950368     DOI: 10.1210/jcem-43-2-364

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Bromocriptine in the treatment of acromegaly.

Authors:  D E Bateman; W M Tunbridge
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

2.  Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants.

Authors:  G N Pavlakis; N Hizuka; P Gorden; P Seeburg; D H Hamer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

3.  Unusual heterogeneity of circulating prolactin in an acromegalic.

Authors:  A D Rogol; R C Eastman; T Manolio; S W Rosen
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

4.  Identification and characterization of specific binding proteins for growth hormone in normal human sera.

Authors:  A C Herington; S Ymer; J Stevenson
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.